All News

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer compared with endocrine therapy alone.

The three-drug combination of Perjeta and Herceptin with Gemzar shows improved progression-free survival in patients with metastatic breast cancer to advance to a phase 3 trial.

Findings from a recent study supported further evaluation of comparing anti–PD-1 to anti–PD-L1 therapy to help determine treatment options for patients with cancer.

A male breast cancer survivor's take on some promising statistics that show a decline in the cancer death rate in the US, but not for every type of cancer.

FDA has given an accelerated approval to Padcev in the treatment of patients with locally advanced or metastatic urothelial cancer.

Personalized treatments have changed the cancer landscape, and continue to change it for patients with renal cell carcinoma.

One breast cancer and melanoma survivor thinks about the long-term impacts of her cancer diagnosis and the silver linings.

Patients with gastrointestinal stromal tumors have a new targeted therapy that looks to tackle secondary mutations after it showed a strong response rate in the clinic.

Cancer mortality rates have declined significantly since 1991; however, certain cancer types have seen slower progression as of recently because of improved screening.

The medication plinabulin is currently being tested in clinical trials to see its benefits in treating chemotherapy-induced neutropenia.

The Bladder Cancer Advocacy Network (BCAN) is pleased to announce two 2020 Young Investigator Awards (YIA), to support the development of outstanding early-career research scientists and clinical cancer research investigators.

This new option may save patients with high-risk non-muscle invasive bladder cancer from having to undergo a radical cystectomy to treat their disease.

Finally, I'm experiencing a little less worry on my cancer journey and gaining some freedom from cancer.

A recent study has found that real acupuncture can not only reduce a patient's cancer pain from various types of cancer, but also reduce their painkiller use.

At 15 years old the Bladder Cancer Advocacy Network looks back and takes a look ahead.

From the largest one-year cancer death rate drop in the US to Supreme Court Justice Ruth Bader Ginsburg announcing she is cancer-free for a fourth time, here’s what is making the headlines in the cancer space this week.

The Food and Drug Administration approved Ayvakit for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumor who exhibited a platelet-derived growth factor receptor alpha exon 18 mutation.

Increasing doses, cutting pills and self-tapering of opioids can lead to safety risks for patients with cancer; however, this is an issue that often goes unaddressed.

Cancer survivors need to keep up with the news. However, reading about a new study or risk factor might make us worry about past choices and/or current options, in a way we can't quite control.

In a new study, researchers set out to prove whether or not there was a statistically significant risk of ovarian cancer from the use of talc-based powder.

The Food and Drug Administration approved Keytruda for the treatment of patients with Bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer.

A physician’s social network is important to determining the adoption of high-value cancer drugs, as researchers have determined peer influence had a strong association with the adoption of Avastin among oncologists across the nation.

One cancer survivor discusses the need to talk to others during and after her treatment, and the healing ability of listening as well.

Launched in April 2018, the podcast hosted by Eleanor Griffith of Grey Genetics tells the stories of people living with genetic mutations that predispose them to cancer or other diseases.

Doing a few hours of exercise per week can help prevent kidney, liver, endometrial, colon and breast cancers, as well as multiple myeloma and non-Hodgkin lymphoma, a large study found.

Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer.

Researchers interviewed 24 cancer survivors to discuss the psychosocial aspects of hearing loss and why patients must advocate for themselves with this long-term condition sooner.

Concurrent chemoradiotherapy with proton radiation can reduce short-term side effects that caused unplanned hospitalizations, with similar disease-free and overall survival, compared with photon radiation.